{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T20:42:42Z","timestamp":1774816962055,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971542"],"award-info":[{"award-number":["81971542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004171"],"award-info":[{"award-number":["82004171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171771"],"award-info":[{"award-number":["82171771"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071817"],"award-info":[{"award-number":["82071817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Young Elite Scientist Sponsorship Program by CACM","award":["CACM-2020-QNRC2-05"],"award-info":[{"award-number":["CACM-2020-QNRC2-05"]}]},{"name":"Hong Kong Research Grants Council General Research Fund","award":["17113319, 17103821, 17111222"],"award-info":[{"award-number":["17113319, 17103821, 17111222"]}]},{"name":"Theme-Based Research Scheme","award":["T12-703\/19R"],"award-info":[{"award-number":["T12-703\/19R"]}]},{"name":"Shenzhen Science and Technology Program","award":["YCYJ20210324114602008"],"award-info":[{"award-number":["YCYJ20210324114602008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00011-022-01660-5","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T10:03:36Z","timestamp":1666865016000},"page":"1577-1588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["GITRL impairs the immunosuppressive function of MDSCs via PTEN-mediated signaling pathway in experimental Sj\u00f6gren syndrome"],"prefix":"10.1007","volume":"71","author":[{"given":"Jie","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Rui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"1660_CR1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sjogren syndrome. Nat Rev Dis Primers. 2016;2:16047. https:\/\/doi.org\/10.1038\/nrdp.2016.47.","journal-title":"Nat Rev Dis Primers"},{"key":"1660_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI. Sj\u00f6gren\u2019s syndrome. The Lancet. 2005;366:321\u201331. https:\/\/doi.org\/10.1016\/s0140-6736(05)66990-5.","journal-title":"The Lancet"},{"key":"1660_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA. Primary Sjogren\u2019s syndrome. N Engl J Med. 2018;378:931\u20139. https:\/\/doi.org\/10.1056\/NEJMcp1702514.","journal-title":"N Engl J Med"},{"key":"1660_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571.","journal-title":"Ann Rheum Dis"},{"key":"1660_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.55563\/clinexprheumatol\/gy6udz","volume":"39","author":"M Mona","year":"2021","unstructured":"Mona M, Mondello S, Hyon JY, Saleh W, Han K, Lee HJ, et al. Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjogren\u2019s syndrome. Clin Exp Rheumatol. 2021;39:795\u2013803. https:\/\/doi.org\/10.55563\/clinexprheumatol\/gy6udz.","journal-title":"Clin Exp Rheumatol"},{"key":"1660_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2249.2010.04188.x","volume":"162","author":"H Tsuboi","year":"2010","unstructured":"Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren\u2019s syndrome. Clin Exp Immunol. 2010;162:53\u201361. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04188.x.","journal-title":"Clin Exp Immunol"},{"key":"1660_CR7","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/art.21764","volume":"54","author":"LJ Dawson","year":"2006","unstructured":"Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscarinic antibodies in primary Sjogren\u2019s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006;54:1165\u201373. https:\/\/doi.org\/10.1002\/art.21764.","journal-title":"Arthritis Rheum"},{"key":"1660_CR8","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41423-021-00688-7","volume":"18","author":"F Xiao","year":"2021","unstructured":"Xiao F, Han M, Rui K, Ai X, Tian J, Zhang W, et al. New insights into follicular helper T cell response and regulation in autoimmune pathogenesis. Cell Mol Immunol. 2021;18:1610\u20132. https:\/\/doi.org\/10.1038\/s41423-021-00688-7.","journal-title":"Cell Mol Immunol"},{"key":"1660_CR9","doi-asserted-by":"publisher","first-page":"604607","DOI":"10.3389\/fimmu.2020.604607","volume":"11","author":"J Tian","year":"2020","unstructured":"Tian J, Hong Y, Zhu Q, Zhou H, Zhang Y, Shen Z, et al. Mesenchymal stem cell enhances the function of MDSCs in experimental Sjogren syndrome. Front Immunol. 2020;11:604607. https:\/\/doi.org\/10.3389\/fimmu.2020.604607.","journal-title":"Front Immunol"},{"key":"1660_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","volume":"9","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren\u2019s syndrome. Nat Rev Rheumatol. 2013;9:544\u201356. https:\/\/doi.org\/10.1038\/nrrheum.2013.110.","journal-title":"Nat Rev Rheumatol"},{"key":"1660_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021. https:\/\/doi.org\/10.1038\/s41577-020-00490-y.","journal-title":"Nat Rev Immunol"},{"key":"1660_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/annrheumdis-2014-205508","volume":"75","author":"C Guo","year":"2016","unstructured":"Guo C, Hu F, Yi H, Feng Z, Li C, Shi L, et al. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis. Ann Rheum Dis. 2016;75:278\u201385. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205508.","journal-title":"Ann Rheum Dis"},{"key":"1660_CR13","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.4049\/jimmunol.1200086","volume":"189","author":"H Yi","year":"2012","unstructured":"Yi H, Guo C, Yu X, Zuo D, Wang XY. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol. 2012;189:4295\u2013304. https:\/\/doi.org\/10.4049\/jimmunol.1200086.","journal-title":"J Immunol"},{"key":"1660_CR14","doi-asserted-by":"publisher","first-page":"331ra40","DOI":"10.1126\/scitranslmed.aae0482","volume":"8","author":"H Wu","year":"2016","unstructured":"Wu H, Zhen Y, Ma Z, Li H, Yu J, Xu ZG, et al. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci Transl Med. 2016;8:331ra40. https:\/\/doi.org\/10.1126\/scitranslmed.aae0482.","journal-title":"Sci Transl Med"},{"key":"1660_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.4049\/jimmunol.1801051","volume":"202","author":"J Tian","year":"2019","unstructured":"Tian J, Rui K, Hong Y, Wang X, Xiao F, Lin X, et al. Increased GITRL impairs the function of myeloid-derived suppressor cells and exacerbates primary Sj\u00f6gren syndrome. J Immunol. 2019;202:1693\u2013703. https:\/\/doi.org\/10.4049\/jimmunol.1801051.","journal-title":"J Immunol"},{"key":"1660_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbcan.2014.04.003","volume":"1846","author":"P Trikha","year":"2014","unstructured":"Trikha P, Carson WE 3rd. Signaling pathways involved in MDSC regulation. Biochim Biophys Acta. 2014;1846:55\u201365. https:\/\/doi.org\/10.1016\/j.bbcan.2014.04.003.","journal-title":"Biochim Biophys Acta"},{"key":"1660_CR17","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1172\/JCI60083","volume":"123","author":"D Vasquez-Dunddel","year":"2013","unstructured":"Vasquez-Dunddel D, Pan F, Zeng Q, Gorbounov M, Albesiano E, Fu J, et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J Clin Invest. 2013;123:1580\u20139. https:\/\/doi.org\/10.1172\/JCI60083.","journal-title":"J Clin Invest"},{"key":"1660_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41419-018-0803-7","volume":"9","author":"FY Mao","year":"2018","unstructured":"Mao FY, Zhao YL, Lv YP, Teng YS, Kong H, Liu YG, et al. CD45(+)CD33(low)CD11b(dim) myeloid-derived suppressor cells suppress CD8(+) T cell activity via the IL-6\/IL-8-arginase I axis in human gastric cancer. Cell Death Dis. 2018;9:763. https:\/\/doi.org\/10.1038\/s41419-018-0803-7.","journal-title":"Cell Death Dis"},{"key":"1660_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/annrheumdis-2017-212619","volume":"78","author":"S Nayar","year":"2019","unstructured":"Nayar S, Campos J, Smith CG, Iannizzotto V, Gardner DH, Colafrancesco S, et al. Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjogren\u2019s syndrome. Ann Rheum Dis. 2019;78:249\u201360. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212619.","journal-title":"Ann Rheum Dis"},{"key":"1660_CR20","doi-asserted-by":"publisher","first-page":"857014","DOI":"10.3389\/fimmu.2022.857014","volume":"13","author":"X Hong","year":"2022","unstructured":"Hong X, Wang X, Rang X, Yin X, Zhang X, Wang R, et al. The shared mechanism and candidate drugs of multiple sclerosis and Sjogren\u2019s syndrome analyzed by bioinformatics based on GWAS and transcriptome data. Front Immunol. 2022;13:857014. https:\/\/doi.org\/10.3389\/fimmu.2022.857014.","journal-title":"Front Immunol"},{"key":"1660_CR21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41423-020-00587-3","volume":"18","author":"K Rui","year":"2021","unstructured":"Rui K, Hong Y, Zhu Q, Shi X, Xiao F, Fu H, et al. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjogren\u2019s syndrome by modulating the function of myeloid-derived suppressor cells. Cell Mol Immunol. 2021;18:440\u201351. https:\/\/doi.org\/10.1038\/s41423-020-00587-3.","journal-title":"Cell Mol Immunol"},{"key":"1660_CR22","doi-asserted-by":"publisher","first-page":"588682","DOI":"10.3389\/fimmu.2020.588682","volume":"11","author":"J Tian","year":"2020","unstructured":"Tian J, Zhang B, Rui K, Wang S. The role of GITR\/GITRL interaction in autoimmune diseases. Front Immunol. 2020;11:588682. https:\/\/doi.org\/10.3389\/fimmu.2020.588682.","journal-title":"Front Immunol"},{"key":"1660_CR23","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.172.8.4686","volume":"172","author":"AP Kohm","year":"2004","unstructured":"Kohm AP, Williams JS, Miller SD. Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. J Immunol. 2004;172:4686\u201390. https:\/\/doi.org\/10.4049\/jimmunol.172.8.4686.","journal-title":"J Immunol"},{"key":"1660_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/eji.200324804","volume":"34","author":"S Ronchetti","year":"2004","unstructured":"Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G, et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol. 2004;34:613\u201322. https:\/\/doi.org\/10.1002\/eji.200324804.","journal-title":"Eur J Immunol"},{"key":"1660_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.autrev.2014.10.011","volume":"14","author":"MG Petrillo","year":"2015","unstructured":"Petrillo MG, Ronchetti S, Ricci E, Alunno A, Gerli R, Nocentini G, et al. GITR+ regulatory T cells in the treatment of autoimmune diseases. Autoimmun Rev. 2015;14:117\u201326. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.011.","journal-title":"Autoimmun Rev"},{"key":"1660_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni759","volume":"3","author":"J Shimizu","year":"2002","unstructured":"Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002;3:135\u201342. https:\/\/doi.org\/10.1038\/ni759.","journal-title":"Nat Immunol"},{"key":"1660_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725\u201334. https:\/\/doi.org\/10.1038\/nri910.","journal-title":"Nat Rev Immunol"},{"key":"1660_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","volume":"20","author":"C Dong","year":"2002","unstructured":"Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol. 2002;20:55\u201372. https:\/\/doi.org\/10.1146\/annurev.immunol.20.091301.131133.","journal-title":"Annu Rev Immunol"},{"key":"1660_CR29","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.jbc.2021.101097","volume":"297","author":"H Li","year":"2021","unstructured":"Li H, Hostager BS, Arkee T, Bishop GA. Multiple mechanisms for TRAF3-mediated regulation of the T cell costimulatory receptor GITR. J Biol Chem. 2021;297:101097. https:\/\/doi.org\/10.1016\/j.jbc.2021.101097.","journal-title":"J Biol Chem"},{"key":"1660_CR30","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.4049\/jimmunol.174.12.7875","volume":"174","author":"EM Esparza","year":"2005","unstructured":"Esparza EM, Arch RH. Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-kappa B activation. J Immunol. 2005;174:7875\u201382. https:\/\/doi.org\/10.4049\/jimmunol.174.12.7875.","journal-title":"J Immunol"},{"key":"1660_CR31","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1007\/s00018-004-4417-0","volume":"61","author":"EM Esparza","year":"2004","unstructured":"Esparza EM, Arch RH. TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation. Cell Mol Life Sci. 2004;61:3087\u201392. https:\/\/doi.org\/10.1007\/s00018-004-4417-0.","journal-title":"Cell Mol Life Sci"},{"key":"1660_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ajpath.2011.11.018","volume":"180","author":"S Wang","year":"2012","unstructured":"Wang S, Shi Y, Yang M, Ma J, Tian J, Chen J, et al. Glucocorticoid-induced tumor necrosis factor receptor family-related protein exacerbates collagen-induced arthritis by enhancing the expansion of Th17 cells. Am J Pathol. 2012;180:1059\u201367. https:\/\/doi.org\/10.1016\/j.ajpath.2011.11.018.","journal-title":"Am J Pathol"},{"key":"1660_CR33","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943\u20137. https:\/\/doi.org\/10.1126\/science.275.5308.1943.","journal-title":"Science"},{"key":"1660_CR34","doi-asserted-by":"publisher","unstructured":"Lee YR, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol 2018; 19:547\u2013562. https:\/\/doi.org\/10.1038\/s41580-018-0015-0.","DOI":"10.1038\/s41580-018-0015-0"},{"key":"1660_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/978-0-387-89520-8_11","volume":"647","author":"G Nocentini","year":"2009","unstructured":"Nocentini G, Riccardi C. GITR: a modulator of immune response and inflammation. Adv Exp Med Biol. 2009;647:156\u201373. https:\/\/doi.org\/10.1007\/978-0-387-89520-8_11.","journal-title":"Adv Exp Med Biol"},{"key":"1660_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2MIR0817-339RR","author":"AM Wallis","year":"2018","unstructured":"Wallis AM, Bishop GA. TRAF3 regulation of inhibitory signaling pathways in B and T lymphocytes by kinase and phosphatase localization. J Leukoc Biol. 2018. https:\/\/doi.org\/10.1002\/JLB.2MIR0817-339RR.","journal-title":"J Leukoc Biol"},{"key":"1660_CR37","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1038\/ncomms4393","volume":"5","author":"S Nakahata","year":"2014","unstructured":"Nakahata S, Ichikawa T, Maneesaay P, Saito Y, Nagai K, Tamura T, et al. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun. 2014;5:3393. https:\/\/doi.org\/10.1038\/ncomms4393.","journal-title":"Nat Commun"},{"key":"1660_CR38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4049\/jimmunol.1203535","volume":"191","author":"W Fujii","year":"2013","unstructured":"Fujii W, Ashihara E, Hirai H, Nagahara H, Kajitani N, Fujioka K, et al. Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J Immunol. 2013;191:1073\u201381. https:\/\/doi.org\/10.4049\/jimmunol.1203535.","journal-title":"J Immunol"},{"key":"1660_CR39","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.4049\/jimmunol.1101816","volume":"188","author":"M Ioannou","year":"2012","unstructured":"Ioannou M, Alissafi T, Lazaridis I, Deraos G, Matsoukas J, Gravanis A, et al. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J Immunol. 2012;188:1136\u201346. https:\/\/doi.org\/10.4049\/jimmunol.1101816.","journal-title":"J Immunol"},{"key":"1660_CR40","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/art.39767","volume":"68","author":"MJ Park","year":"2016","unstructured":"Park MJ, Lee SH, Kim EK, Lee EJ, Park SH, Kwok SK, et al. Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in the Sanroque mouse model of systemic lupus erythematosus. Arthritis Rheumatol. 2016;68:2717\u201327. https:\/\/doi.org\/10.1002\/art.39767.","journal-title":"Arthritis Rheumatol"},{"key":"1660_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2015.08.010","volume":"65","author":"H Zhang","year":"2015","unstructured":"Zhang H, Huang Y, Wang S, Fu R, Guo C, Wang H, et al. Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts. J Autoimmun. 2015;65:82\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2015.08.010.","journal-title":"J Autoimmun"},{"key":"1660_CR42","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.4049\/jimmunol.179.8.5228","volume":"179","author":"B Zhu","year":"2007","unstructured":"Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, et al. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol. 2007;179:5228\u201337.","journal-title":"J Immunol"},{"key":"1660_CR43","doi-asserted-by":"publisher","first-page":"340751","DOI":"10.1155\/2013\/340751","volume":"2013","author":"X Gan","year":"2013","unstructured":"Gan X, Feng X, Gu L, Tan W, Sun X, Lv C, et al. Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjogren\u2019s syndrome. Clin Dev Immunol. 2013;2013:340751. https:\/\/doi.org\/10.1155\/2013\/340751.","journal-title":"Clin Dev Immunol"},{"key":"1660_CR44","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3389\/fimmu.2017.01840","volume":"8","author":"M Jiang","year":"2017","unstructured":"Jiang M, Chen J, Zhang W, Zhang R, Ye Y, Liu P, et al. Interleukin-6 trans-signaling pathway promotes immunosuppressive myeloid-derived suppressor cells via suppression of suppressor of cytokine signaling 3 in breast cancer. Front Immunol. 2017;8:1840. https:\/\/doi.org\/10.3389\/fimmu.2017.01840.","journal-title":"Front Immunol"},{"key":"1660_CR45","doi-asserted-by":"publisher","first-page":"11676","DOI":"10.1074\/jbc.M112.441402","volume":"288","author":"LM Hix","year":"2013","unstructured":"Hix LM, Karavitis J, Khan MW, Shi YH, Khazaie K, Zhang M. Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells. J Biol Chem. 2013;288:11676\u201388. https:\/\/doi.org\/10.1074\/jbc.M112.441402.","journal-title":"J Biol Chem"},{"key":"1660_CR46","doi-asserted-by":"publisher","first-page":"7682827","DOI":"10.1155\/2019\/7682827","volume":"2019","author":"S Colafrancesco","year":"2019","unstructured":"Colafrancesco S, Ciccacci C, Priori R, Latini A, Picarelli G, Arienzo F, et al. STAT4, TRAF3IP2, IL10, and HCP5 polymorphisms in Sjogren\u2019s syndrome: association with disease susceptibility and clinical aspects. J Immunol Res. 2019;2019:7682827. https:\/\/doi.org\/10.1155\/2019\/7682827.","journal-title":"J Immunol Res"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-022-01660-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T16:12:26Z","timestamp":1668269546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-022-01660-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1660"],"URL":"https:\/\/doi.org\/10.1007\/s00011-022-01660-5","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no financial conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}